ORGANIC
LETTERS
2005
Vol. 7, No. 18
4025-4028
Regioselective and Diastereoselective
Amination with Use of Chlorosulfonyl
Isocyanate: A Short and Efficient
Synthesis of (−)-Cytoxazone
Ji Duck Kim, In Su Kim, Cheng Hua Jin, Ok Pyo Zee, and Young Hoon Jung*
College of Pharmacy, Sungkyunkwan UniVersity, Suwon 440-746, Korea
Received June 29, 2005
ABSTRACT
The total synthesis of (
are the regioselective and stereoselective introduction of a N-protected amine group, using the CSI reaction of the anti-1,2-dimethyl ether 3,
and the subsequent regioselective cyclization of the N-protected amino diol 13 to give the 2-oxazolidinone unit of ( )-cytoxazone 1.
−)-cytoxazone 1 was achieved in six linear steps (34% overall yield) from p-anisaldehyde. The key steps in this route
−
Cytoxazone 1 is a novel cytokine modulator that was isolated
from Streptomyces sp., and interferes with cytokine IL4,
IL10, and IgG production via the selective inhibition of the
signaling pathway in Th2 cells. Its structure was determined
to be (4R,5R)-5-hydroxymethyl-4-p-methoxyphenyl-1,3-ox-
azolidin-2-one based on the NMR, CD, and X-ray data.1
Due to its potent bioactivity and relatively simple structure,
several methods of synthesizing (-)-cytoxazone and its trans-
diastereoisomer (4-epicytoxazone) have recently been re-
ported. These include Sharpless asymmetric dihydroxylation
and the introduction of amine,2 Sharpless asymmetric ami-
nohydroxylation,3 an asymmetric epoxidation and the regio-
selective introduction of azide,4 the Petasis reaction,5 an
asymmetric aldol reaction,6 an imino-1,2-Wittig rearrange-
ment,7 the addition of Grignard reagents to the protected
imines,8 and the conjugated addition of chiral lithium amide.9
This paper presents our synthetic approach to (-)-cytox-
azone, based on the regioselective and diastereoselective
chlorosulfonyl isocyanate (CSI) reaction.10
The retrosynthetic scheme is shown below (Scheme 1) and
the key steps are the regioselective and diastereoselective
introduction of a N-protected amine group into an anti-1,2-
dimethyl ether 3 to directly give the protected anti-1,2-amino
(4) Tosaki, S.-y.; Tsuji, R.; Ohshima, T.; Shibasaki, M. J. Am. Chem.
Soc. 2005, 127, 2147.
(5) Sugiyama, S.; Arai, S.; Ishii, K. Tetrahedron: Asymmetry 2004, 15,
3149.
(6) (a) Carda, M.; Gonzalez, F.; Sanchez, R.; Marco, J. A. Tetrahedron:
Asymmetry 2002, 13, 1005. (b) Carter, P. H.; LaPorte, J. R.; Scherle, P. A.;
Decicco, C. P. Bioorg. Med. Chem. Lett. 2003, 13, 1237. (c) Kumar, A. R.;
Bhaskar, G.; Madhan, A.; Rao, B. V. Synth. Commun. 2003, 33, 2907.
(7) Miyata, O.; Asai, H.; Naito, T. Synlett 1999, 12, 1915.
(8) Madham, A.; Kumar, A. R.; Rao, B. V. Tetrahedron: Asymmetry
2001, 12, 2009.
(9) Davies, S. G.; Hughes, D. G.; Nicholson, R. L.; Smith, A. D.; Wright,
A. J. Org. Biomol. Chem. 2004, 2, 1549.
(10) (a) Kim, J. D.; Lee, M. H.; Lee, M. J.; Jung, Y. H. Tetrahedron
Lett. 2000, 41, 5073. (b) Kim, J. D.; Lee, M. H.; Han, G.; Park, H.; Zee,
O. P.; Jung, Y. H. Tetrahedron 2001, 57, 8257. (c) Kim, J. D.; Zee, O. P.;
Jung, Y. H. J. Org. Chem. 2003, 68, 3721. (d) Kim, J. D.; Kim, I. S.; Jin,
C. H.; Zee, O. P.; Jung, Y. H. Tetrahedron Lett. 2005, 46, 1079.
* To whom correspondence should be addressed. Fax: 8231-290-5403.
(1) (a) Kakeya, H.; Morishita, M.; Kobinata, K.; Osono, M.; Osada, H.
J. Antibiot. 1998, 51, 1126. (b) Kakeya, H.; Morishita, M.; Koshino, H.;
Morita, T.; Kobayashi, K.; Osada, H. J. Org. Chem. 1999, 64, 1052.
(2) (a) Sakamoto, Y.; Shiraishi, A.; Jeong, S.; Nakata, T. Tetrahedron
Lett. 1999, 40, 4203. (b) Seki, M.; Mori, K. Eur. J. Org. Chem. 1999, 2965.
(c) Park, J. N.; Ko, S. Y.; Koh, H. Y. Tetrahedron Lett. 2000, 41, 5553. (d)
Boruwa, J.; Borah, J. C.; Kalita, B.; Barua, N. C. Tetrahedron Lett. 2004,
45, 7355.
(3) Milicevic, S.; Matovic, R.; Saicic, R. N. Tetrahedron Lett. 2004, 45,
955.
10.1021/ol0515255 CCC: $30.25
© 2005 American Chemical Society
Published on Web 08/12/2005